GB1367608A - Oral pharmaceutical dosage form - Google Patents

Oral pharmaceutical dosage form

Info

Publication number
GB1367608A
GB1367608A GB1143873A GB1143873A GB1367608A GB 1367608 A GB1367608 A GB 1367608A GB 1143873 A GB1143873 A GB 1143873A GB 1143873 A GB1143873 A GB 1143873A GB 1367608 A GB1367608 A GB 1367608A
Authority
GB
United Kingdom
Prior art keywords
dosage form
pharmaceutical dosage
oral pharmaceutical
oral
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1143873A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biological Concepts Inc
Original Assignee
Biological Concepts Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biological Concepts Inc filed Critical Biological Concepts Inc
Priority to GB1143873A priority Critical patent/GB1367608A/en
Priority to FR7315141A priority patent/FR2226992B1/fr
Publication of GB1367608A publication Critical patent/GB1367608A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
GB1143873A 1973-03-09 1973-03-09 Oral pharmaceutical dosage form Expired GB1367608A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1143873A GB1367608A (en) 1973-03-09 1973-03-09 Oral pharmaceutical dosage form
FR7315141A FR2226992B1 (enrdf_load_stackoverflow) 1973-03-09 1973-04-26

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1143873A GB1367608A (en) 1973-03-09 1973-03-09 Oral pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
GB1367608A true GB1367608A (en) 1974-09-18

Family

ID=9986269

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1143873A Expired GB1367608A (en) 1973-03-09 1973-03-09 Oral pharmaceutical dosage form

Country Status (2)

Country Link
FR (1) FR2226992B1 (enrdf_load_stackoverflow)
GB (1) GB1367608A (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609542A (en) * 1978-12-22 1986-09-02 Elan Corporation, P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
WO1994023700A1 (en) * 1993-04-22 1994-10-27 Rijksuniversiteit Gent Laboratorium Voor Farmaceutische Technologie High release solid preparation, preparation and use thereof
WO2004110408A3 (en) * 2003-06-13 2005-04-14 John Claude Savoir Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609542A (en) * 1978-12-22 1986-09-02 Elan Corporation, P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
US4726951A (en) * 1978-12-22 1988-02-23 Elan Corporation P.L.C. New pharmaceutical forms for administration of medicaments by oral route, with programmed release
WO1994023700A1 (en) * 1993-04-22 1994-10-27 Rijksuniversiteit Gent Laboratorium Voor Farmaceutische Technologie High release solid preparation, preparation and use thereof
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
WO2004110408A3 (en) * 2003-06-13 2005-04-14 John Claude Savoir Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
EP1820494A3 (en) * 2003-06-13 2007-09-19 Savoir, John Claude Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
EP1844765A1 (en) * 2003-06-13 2007-10-17 Skendi Finance, Ltd. Contraception and hormone replacement therapy comprising a combination of estrogene with cholesterol and progesterone
US7589082B2 (en) 2003-06-13 2009-09-15 Skendi Finance Ltd Pharmaceutical formulation for contraception and hormone-replacement therapy
EA012783B1 (ru) * 2003-06-13 2009-12-30 Джон Клод Савуар Фармацевтическая композиция для контрацепции и заместительной гормональной терапии
US8163722B2 (en) 2003-06-13 2012-04-24 Skendi Finance Ltd. Pharmaceutical formulation for contraception and hormone-replacement therapy
EA018356B1 (ru) * 2003-06-13 2013-07-30 Джон Клод Савуар Микросферы эстрадиола и холестерина

Also Published As

Publication number Publication date
FR2226992A1 (enrdf_load_stackoverflow) 1974-11-22
FR2226992B1 (enrdf_load_stackoverflow) 1977-01-28

Similar Documents

Publication Publication Date Title
ZA741963B (en) Oral drug preparations
ZA743934B (en) Pharmaceutical compositions
IL42232A0 (en) Dry medicines for oral administration
AU7155674A (en) Pharmaceutical dispersible powder
ZA751007B (en) Oral pharmaceutical preparation
IL51096A0 (en) Novel pharmaceutical dosage form
HK72578A (en) Pharmaceutical compositions
IL44646A0 (en) Novel pharmaceutical tablets
ZA744373B (en) Pharmaceutical compositions
AU7201374A (en) Pharmaceutical compositions
ZA742956B (en) Pharmaceutical compositions containing triazolo-isoquinoline derivatives
ZA7461B (en) Pharmaceutical formulation
ZA745756B (en) Pharmaceutical compositions
ZA744488B (en) Pharmaceutical compositions
ZA747276B (en) Pharmaceutical compositions
ZA742064B (en) Pharmaceutical compositions
ZA746271B (en) Pharmaceutical compositions
AU7349374A (en) Medicinal composition
ZA745114B (en) A medicament- thiazole 5-methanol and pharmaceutical compositions containing
GB1367608A (en) Oral pharmaceutical dosage form
CY965A (en) Pharmaceutical compositions
AU5512273A (en) Medicinal preparations for oral use
AU7194974A (en) Pharmaceutical product
ZA741050B (en) Pharmaceutical compositions
ZA745332B (en) Oral preparations

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees